Preventing Addiction Related Suicide (PARS) - Controlled Trial of Secondary Suicide Prevention

预防成瘾相关自杀 (PARS) - 二级自杀预防对照试验

• 批准号: 9926359
• 负责人: KATHERINE ANNE COMTOIS
• 金额: $ 0.85万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-15 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9926359
• 关键词: Address; Administrator; Adult; Alcohol or Other Drugs use; Attitude; Behavior Therapy; Behavioral; Belief; Caring; Client; Clinic; Communities; Country; Data; Development; Dose; Drug abuse; Effectiveness; Enrollment; Evidence based practice; Family; Feeling suicidal; Friends; Goals; Group Therapy; Guidelines; Hour; Individual; Institutes; Intoxication; Knowledge; Mediating; Modality; National Institute of Drug Abuse; Outcome; Participant; Pharmaceutical Preparations; Population; Positioning Attribute; Prevention program; Prevention strategy; Professional counselor; Protocols documentation; Publishing; Randomized; Relapse; Reporting; Research; Research Personnel; Sampling; Substance Use Disorder; Suicide; Suicide attempt; Suicide prevention; Testing; Time; United States Substance Abuse and Mental Health Services Administration; Washington; addiction; alcohol abuse therapy; alcohol use disorder; base; community setting; compare effectiveness; design; effectiveness trial; follow up assessment; follow-up; help-seeking behavior; high risk; high risk population; improved; improved outcome; innovation; model design; multiple drug use; novel; outpatient programs; post intervention; prevent; programs; prospective; psychoeducational; public health relevance; selective prevention; skills; suicidal; suicidal behavior; suicidal risk; treatment as usual; treatment group; treatment site

Project Abstract/Summary Studies consistently show suicide and suicidal behaviors are highly related to substance use disorders (SUDs). Recent reviews find that the risk of suicide is 10-17 times higher for people using multiple drugs, injecting drugs, and for alcohol use disorders. Utilizing clearly established Stage I guidelines for developing and adapting behavioral interventions, as well as information included in a SAMHSA Treatment Improvement Protocol (TIP50) on suicide and addiction, the current Investigators developed the Preventing Addiction Related Suicide (PARS) program by integrating the content of empirically-supported secondary suicide prevention programs. PARS is a psychoeducational program taught as a single 3 hour module integrated into a standard group therapy-oriented Intensive Outpatient Program (IOP), the most common form of community drug abuse treatment.9 PARS was conceptualized and developed with a team of community treatment leaders who advised on its scope, duration, and approach. Community partners reviewed early drafts and all pilot testing was conducted in community treatment settings. Pilot testing of PARS demonstrated significant post- intervention increases in client knowledge of suicide and decreases in maladaptive attitudes toward suicide; both were maintained at 1-month follow-up. The likelihood of positive help seeking to prevent suicide for themselves as well as for a friend and for family all doubled for the month after the program compared to the month before. Given these promising Stage I results in Stage III settings, we propose a fully-powered Stage III effectiveness trial of PARS compared to Treatment-As-Usual (TAU) using a randomized stepped wedge design with 900 clients in 15 community addiction treatment sites in Washington State to replicate the pilot findings and evaluate how the mechanisms of improving accurate information and attitudes about suicide promote help-seeking. This proposal is innovative in its topic and development in community settings as well as its use of a stepped wedge design. Community treatment agencies, by integrating PARS into their IOP group treatment, are in a unique position to act as key players in the national suicide prevention strategy by providing accurate suicide prevention information, improving attitudes toward suicide, and increasing help- seeking skills to one of the most high-risk suicidal populations in the country.

项目摘要/总结 研究一致表明自杀和自杀行为与药物滥用障碍 (SUD) 高度相关。 最近的评论发现，使用多种药物、注射药物的人自杀风险高出 10-17 倍 药物和酒精使用障碍。利用明确制定的第一阶段指导方针来开发和 调整行为干预措施以及 SAMHSA 治疗改进中包含的信息 关于自杀和成瘾的协议（TIP50），目前的研究人员制定了预防成瘾 相关自杀（PARS）计划通过整合经验支持的继发性自杀的内容 预防计划。 PARS 是一个心理教育课程，作为一个 3 小时的模块进行教学，并集成到 以标准团体治疗为导向的强化门诊计划 (IOP)，最常见的社区形式 药物滥用治疗。9 PARS 是由社区治疗领导团队构思和开发的 谁就其范围、持续时间和方法提供了建议。社区合作伙伴审查了早期草案和所有试点 测试是在社区治疗环境中进行的。 PARS 的试点测试表明， 干预增加了服务对象对自杀的了解，并减少了对自杀的适应不良态度； 均维持1个月随访。寻求积极帮助以防止自杀的可能性 与参加该计划后的一个月相比，他们自己以及朋友和家人的关注度都增加了一倍 一个月前。鉴于第一阶段在第三阶段设置中取得的这些有希望的结果，我们提出了一个全动力的第三阶段 使用随机阶梯楔进行 PARS 与常规治疗 (TAU) 比较的有效性试验 与华盛顿州 15 个社区成瘾治疗点的 900 名客户一起设计，以复制该试点项目 研究结果并评估如何改善有关自杀的准确信息和态度的机制 促进寻求帮助。该提案的主题和社区环境的发展也具有创新性 由于其采用了阶梯式楔形设计。社区治疗机构，将 PARS 纳入其 IOP 团体治疗，在国家自杀预防战略中发挥着关键作用，具有独特的地位 提供准确的自杀预防信息，改善对自杀的态度，并增加帮助- 为该国自杀风险最高的人群之一寻求技能。